Cancer
Malignant Liver Neoplasm
CI-CAN-00003177Explore in graph →
Top-level907 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003177Explore in graph →
Clinical trials
4,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (462)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02828865 | A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers | completed | N/A | 18 | National Taiwan University HospitalOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT03267290 | Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRI | completed | N/A | 12 | National Taiwan University HospitalOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT03575806 | Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection | completed | Phase 2 | 52 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04415567 | Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation | completed | — | 23 | Jinyang GuOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT04412161 | Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP | completed | — | 50 | Inonu UniversityOTHER | 0 | Jun 2, 2020 | clinicaltrials |
| NCT01331135 | Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors(Aflac ST0901) | completed | Phase 1 | 18 | Emory UniversityOTHER | 1 | May 29, 2020 | clinicaltrials |
| NCT01154816 | Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia | completed | Phase 2 | 118 | Children's Oncology GroupNETWORK | 2 | May 13, 2020 | clinicaltrials |
| NCT00913757 | A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area | completed | — | 1,871 | National Cancer Institute (NCI)NIH | 1 | May 4, 2020 | clinicaltrials |
| NCT02834546 | Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma(ACTES) | completed | — | 143 | University Hospital, BordeauxOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT01775501 | Sorafenib + mFOLFOX for Hepatocellular Carcinoma | completed | Phase 2 | 40 | Massachusetts General HospitalOTHER | 1 | Apr 22, 2020 | clinicaltrials |
| NCT01877187 | Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer | completed | Phase 2 | 39 | Yale UniversityOTHER | 1 | Apr 15, 2020 | clinicaltrials |
| NCT02716766 | Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 46 | The University of Hong KongOTHER | 1 | Apr 10, 2020 | clinicaltrials |
| NCT03578874 | SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC | completed | Phase 2 | 15 | The University of Hong KongOTHER | 1 | Apr 9, 2020 | clinicaltrials |
| NCT03806218 | Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC | completed | N/A | 77 | Seoul National University HospitalOTHER | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03594188 | Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy | completed | N/A | 24 | RenJi HospitalOTHER | 1 | Apr 6, 2020 | clinicaltrials |
| NCT01507168 | A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma | completed | Phase 2 | 185 | Hoffmann-La RocheINDUSTRY | 13 | Apr 3, 2020 | clinicaltrials |
| NCT02390843 | Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors(AflacST1402) | completed | Phase 1 | 13 | Emory UniversityOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT01075555 | Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis | completed | Phase 3 | 323 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Mar 30, 2020 | clinicaltrials |
| NCT02358070 | Epidemiologic Study of Hepatocellular Carcinoma in the US | completed | — | 45 | Stanford UniversityOTHER | 1 | Mar 24, 2020 | clinicaltrials |
| NCT03699657 | Dual and Single Switching Monopolar RFA Using Separable Clustered Electrode for Treatment of HCC | completed | N/A | 86 | Seoul National University HospitalOTHER | 1 | Mar 20, 2020 | clinicaltrials |
| NCT00918333 | Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma | completed | Phase 1 / Phase 2 | 124 | Mayo ClinicOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT01347333 | Stereotactic Body Radiotherapy for Liver Tumors | completed | N/A | 23 | Mercy ResearchOTHER | 1 | Mar 3, 2020 | clinicaltrials |
| NCT00007813 | Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors | completed | Phase 1 | 21 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT00717756 | Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial | completed | Phase 2 | 41 | Brown UniversityOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT01438476 | Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas | completed | Phase 3 | 178 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2020 | clinicaltrials |
| NCT04266548 | Arterial Base Fluorescence Segmental Positive Staining | completed | N/A | 8 | Chang Gung Memorial HospitalOTHER | 1 | Feb 12, 2020 | clinicaltrials |
| NCT01833299 | Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma | completed | Phase 3 | 120 | Sun Yat-sen UniversityOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT01497444 | Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery | completed | Phase 1 | 24 | Alliance for Clinical Trials in OncologyOTHER | 1 | Feb 6, 2020 | clinicaltrials |
| NCT02240433 | A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC) | completed | Phase 1 | 9 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 5, 2020 | clinicaltrials |
| NCT03203005 | IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients | completed | Phase 1 / Phase 2 | 22 | National Cancer Institute, NaplesOTHER | 5 | Feb 5, 2020 | clinicaltrials |
| NCT04106453 | Navigated Laparoscopic Microwave Ablation of Tumor Mimics in Pig Liver - an Ex-vivo Trial | completed | N/A | 4 | Universitätsklinikum KölnOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT04257240 | Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury(annie-liver) | completed | — | 230 | Aretaieion University HospitalOTHER | 0 | Feb 5, 2020 | clinicaltrials |
| NCT03804593 | HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) | completed | — | 175 | Epigenomics, IncINDUSTRY | 1 | Jan 30, 2020 | clinicaltrials |
| NCT00040846 | Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies | completed | Phase 2 | 60 | Fred Hutchinson Cancer CenterOTHER | 2 | Jan 29, 2020 | clinicaltrials |
| NCT02548780 | LifePearl-Doxo Pharmacokinetic (PK) Study | completed | N/A | 15 | Terumo Europe N.V.INDUSTRY | 3 | Jan 27, 2020 | clinicaltrials |
| NCT03053596 | LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) | completed | — | 102 | Terumo Europe N.V.INDUSTRY | 2 | Jan 27, 2020 | clinicaltrials |
| NCT02409524 | An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects | completed | Phase 2 | 15 | Mirror Biologics, Inc.INDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT03159585 | To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors | completed | Phase 1 | 6 | Zhujiang HospitalOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT00006251 | Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer | completed | Phase 1 / Phase 2 | 21 | Fred Hutchinson Cancer CenterOTHER | 2 | Jan 21, 2020 | clinicaltrials |
| NCT00014235 | Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies | completed | N/A | 160 | Fred Hutchinson Cancer CenterOTHER | 3 | Jan 21, 2020 | clinicaltrials |
| NCT00078858 | Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant | completed | Phase 1 / Phase 2 | 37 | Fred Hutchinson Cancer CenterOTHER | 3 | Jan 18, 2020 | clinicaltrials |
| NCT00003196 | Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma | completed | N/A | 63 | Fred Hutchinson Cancer CenterOTHER | 3 | Dec 27, 2019 | clinicaltrials |
| NCT00341705 | The Second Multicenter Hemophilia Cohort Study | completed | — | 2,565 | National Cancer Institute (NCI)NIH | 8 | Dec 17, 2019 | clinicaltrials |
| NCT00825877 | Long-term Follow-up of HALT-C Sustained Virological Responders | completed | — | 140 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT02541370 | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 | completed | Phase 1 / Phase 2 | 20 | Chinese PLA General HospitalOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT02730611 | Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma(METSLIVER) | completed | — | 124 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01326702 | Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors | completed | Phase 1 / Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT01334112 | Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma(AXITINIB) | completed | Phase 2 | 30 | University Health Network, TorontoOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01853618 | Tremelimumab With Chemoembolization or Ablation for Liver Cancer | completed | Phase 1 / Phase 2 | 61 | National Cancer Institute (NCI)NIH | 1 | Dec 10, 2019 | clinicaltrials |
Data updated 24 days agoSource updated Jul 7, 2020source: clinicaltrials